Protein shown to play a key role in normal development of nervous system

A protein that enables nerve cells to communicate with each other plays a key role in controlling the developing nervous system. Research into how that protein helps precise connections to form among nerve cells may provide a basis for eventual treatments for patients who suffer injuries to their nervous system, including spinal cord injury.

"This expands our basic knowledge of how the nervous system develops in animals and humans," said study leader Robert Kalb, M.D., a neurologist at The Children's Hospital of Philadelphia. Kalb and colleagues published two studies in the Journal of Neuroscience.

The first study, published Oct. 1, showed that the protein GluR1, which is a receptor for the neurotransmitter glutamate, promotes the growth of dendrites, both in nerve cell cultures and in the nervous system of mice. Dendrites are branching extensions of nerve cells that carry signals into the cell. The most vigorous dendrite growth occurs shortly after birth, when GluR1 is present on the surface of the cell. As neurons mature, GluR1 is lost from the cell surface of some neurons, and dendrites stop growing.

Kalb and colleagues showed that suppressing GluR1 activity reduced dendrite growth, and led to poor development of connections between neurons. As a result of these defects, mice displayed less strength and less endurance on treadmill tests. On the other hand, using genetic manipulation that led to cell surface expression of GluR1 protein in adult mice led to supernormal motor performance, as shown by longer duration on treadmills.

"Our observations could be relevant to helping patients recover motor function after they suffer an injury to the spinal cord or other parts of the nervous system," said Kalb. "Often neural circuits remain intact after an injury, and are capable of reorganizing themselves, given the proper stimulation. If we can eventually manipulate this protein's activity in neurons, we might enhance communication among those neurons, and allow patients to receiver greater benefit from therapeutic exercises."

The second study by Kalb and colleagues, published Oct. 8, described the molecular pathways by which GluR1 binds with another protein, SAP97, to control dendrite growth during the early postnatal period. "Our work suggests that GluR1 brings the scaffolding protein SAP97 to the membrane of nerve cells, where it can receive pro-growth signals to build dendrites."

Although both studies were performed in mice, the neurodevelopmental process is considered to be similar for all mammals. "The first few weeks of postnatal life are a critical period for sculpting the architecture of the nervous system," added Kalb. "Greater understanding of how neural architecture develops normally may give us insight into how to intervene when things go wrong."

Source: Children's Hospital of Philadelphia

Related stories:

Cocaine: How addiction develops
Permanent drug seeking and relapse after renewed drug administration are typical behavioral patterns of addiction. Molecular changes at the connection points in the brain's reward center are directly responsible for this. This finding was published by a research team from the Institute of Mental Health (ZI) in Mannheim, the German Cancer Research Center (DKFZ) in Heidelberg and the University of Geneva, Switzerland, in the latest issue of Neuron. The results provide researchers with new approaches in the medical treatment of drug addiction.
Protection from the own immune system
Some 80,000 people in Germany suffer from multiple sclerosis – their immune system attacks and destroys healthy nerve tissue. Researchers at the Heidelberg University Hospital and the German Cancer Research Center in Heidelberg have succeeded in vaccinating mice with specially treated, autologous immune cells and preventing them from developing encephalitis, which is similar to multiple sclerosis in humans. A protein of the nervous system, that is the target of the harmful immune reaction in multiple sclerosis, was placed on the surface of the cells; the cells were treated with an agent that suppresses immune defense.
New molecular insight into vertebrate brain development
In the December 1st issue of G&D, Dr. Fred H. Gage (The Salk Institute for Biological Studies) and colleagues reveal a role for the Hippo signaling pathway in the regulation of vertebrate neural development, identifying new factors – and potential therapeutic targets – that may be involved in congenital brain size disorders and neurological tumor formation.
Researchers find link between nicotine addiction and autism
Scientists have identified a relationship between two proteins in the brain that has links to both nicotine addiction and autism. The finding has led to speculation that existing drugs used to curb nicotine addiction might serve as the basis for potential therapies to alleviate the symptoms of autism.
Breakthrough in cell-type analysis offers new ways to study development and disease
(PhysOrg.com) -- Like skilled assassins, many diseases seem to know exactly what types of cells to attack. While decimating one cadre of cells, diseases will inexplicably spare a seemingly identical group of neighbors. What makes cells vulnerable or not depends largely on the kinds and amounts of proteins they produce — their “translational profile,” in the lingo of molecular biology. For this reason, scientists have struggled to parse the subtle molecular differences among the hundreds of specialized cell types that are tangled together in tissues like the brain.
Researchers identify toehold for HIV's assault on brain
Scientists have unraveled in unprecedented detail the cascade of events that go wrong in brain cells affected by HIV, a virus whose assault on the nervous system continues unabated despite antiviral medications that can keep the virus at bay for years in the rest of the body.
Breakthrough in cell-type analysis offers new ways to study development and disease
Like skilled assassins, many diseases seem to know exactly what types of cells to attack. While decimating one cadre of cells, diseases will inexplicably spare a seemingly identical group of neighbors. What makes cells vulnerable or not depends largely on the kinds and amounts of proteins they produce - their "translational profile," in the lingo of molecular biology. For this reason, scientists have struggled to parse the subtle molecular differences among the hundreds of specialized cell types that are tangled together in tissues like the brain.
In the war against diseases, nerve cells need their armor
In a new study, researchers at the Montreal Neurological Institute (MNI), McGill University, and the Université de Montréal have discovered an essential mechanism for the maintenance of the normal structure of myelin, the protective covering that insulates and supports nerve cells (neurons). Up until now, very little was known about myelin maintenance. This new information provides vital insight into diseases such as Multiple Sclerosis (MS) and other progressive demyelinating diseases in which myelin is destroyed, causing irreversible damage and disrupting the nerve cells' ability to transmit messages.

News discussion:

Medicine & Health news